SynthesisInternational journal of molecular sciences2026
Mirvetuximab Soravtansine in the Treatment of Chemotherapy-Resistant Ovarian Cancer: A Systematic Review.
Natalia Picheta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.